Form 4: Director Richard Pops Executes NBIX Stock Option Plan

Neurocrine Biosciences Director Richard Pops exercised 15,000 stock options and sold the resulting shares under a pre-arranged 10b5-1 trading plan.

Summary

• Director Richard F. Pops exercised 15,000 non-qualified stock options at a strike price of $47.89.
• The resulting 15,000 shares were sold at a weighted average price of $157.6507 per share.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2026.
• Following these transactions, the director retains direct ownership of 34,480 shares of Neurocrine Biosciences common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction was pre-planned and represents routine portfolio management by an insider.

Positives

• The transaction was conducted under a pre-established Rule 10b5-1 trading plan, indicating a systematic approach to liquidity rather than reactive selling.
• The director maintains a significant remaining equity stake of 34,480 shares.

Negatives

• The transaction represents a divestment of 15,000 shares by a member of the board of directors.

Risks

• The options exercised were set to expire on May 20, 2026, necessitating action to capture value before expiration.

Future Outlook

No forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives and directors to manage personal portfolios and liquidity, particularly as stock options approach their expiration dates.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate insiders to avoid potential conflicts of interest or allegations of insider trading.
• The exercise of options near their expiration date is a common and expected behavior for long-term equity compensation holders.

Stakeholder Impact

• Minimal impact on shareholders as the sale was executed through a pre-arranged plan.

Next Steps

• No further actions required by the reporting person regarding this specific transaction.

Key Dates

Keywords

NBIX, Neurocrine Biosciences, Insider Trading, Form 4, Stock Options, 10b5-1 Plan